HRT Financial’s Belite Bio BLTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$893K Buy
+5,259
New +$854K ﹤0.01% 2467
2026
Q2
– Sell
-10,922
Closed -$1.74M – 4242
2026
Q1
$1.74M Buy
10,922
+2,758
+34% +$464K ﹤0.01% 1706
2025
Q4
$1.3M Buy
+8,164
New +$967K ﹤0.01% 1562
2025
Q2
– Sell
-4,117
Closed -$272K – 2642
2025
Q1
$272K Buy
+4,117
New +$248K ﹤0.01% 1827
2024
Q3
– Sell
-5,409
Closed -$247K – 2445
2024
Q2
$247K Buy
+5,409
New +$234K ﹤0.01% 1580

Other funds holding BLTE

HRT Financial's BLTE Position: Q3 2026 in Review

HRT Financial opened a new position in Belite Bio (BLTE) in Q3 2026: 5,259 shares worth $893K. The stake represents ﹤0.01% of the portfolio and ranks #2467 among its holdings. This is a return to the name: HRT Financial previously reported a position in BLTE as recently as Q1 2026.

HRT Financial first reported a position in BLTE in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.74M in Q1 2026. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

  • HRT Financial held 5,259 shares of Belite Bio worth $893K as of Q3 2026.
  • Belite Bio was a new HRT Financial position in Q3 2026.
  • Belite Bio made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #2467 holding.
  • HRT Financial first reported a position in Belite Bio in Q2 2024 and has held it in 5 quarters since.
  • HRT Financial's Belite Bio position peaked at $1.74M in Q1 2026.
  • 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.